-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Regenerex Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2019 to Q3 2024.
- Regenerex Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$271K, a 1647% decline year-over-year.
- Regenerex Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$327K, a 312% decline year-over-year.
- Regenerex Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was -$78K, a 89.5% decline from 2022.
- Regenerex Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was -$41.2K, a 35.5% increase from 2021.
- Regenerex Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was -$63.8K, a 34.3% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)